Stewart A Campbell

Stewart A Campbell is from Greater Boston. Stewart is currently Chief Executive Officer at Vertero Therapeutics, Inc. at Vertero Therapeutics, Inc., located in Woburn, Massachusetts, United States. Stewart also works as Independent Director at Concerto Biosciences, a job Stewart has held since Nov 2024. In Stewart's previous role as a Chief Executive Officer at Axial Therapeutics, Inc., Stewart worked in Woburn, Massachusetts, United States until Oct 2025. Prior to joining Axial Therapeutics, Inc., Stewart was a Senior Vice President Preclinical R&D at Axial Biotherapeutics, Inc. and held the position of Senior Vice President Preclinical R&D at Waltham, Massachusetts. Prior to that, Stewart was a Vice President, Early Stage Development at Axial Biotherapeutics, Inc., based in Greater Boston Area from Feb 2017 to Dec 2018. Stewart started working as Head, Business Development and Product Management, Carbohydrates at CordenPharma in Greater Boston Area in Nov 2013. From Oct 2006 to Oct 2013, Stewart was Vice President, Research & Development at Ancora Pharmaceuticals Inc.. Prior to that, Stewart was a Vice President, Chemistry & Preclinical Development at Surface Logix from Oct 2000 to Oct 2006. Stewart started working as Director, Technical Operations at Insmed in Jan 1997.